All research
2026-07-15 PubMed

Review details key methods and factors for identifying pyroptosis, clarifying its dual role in cancer.

How to recognize if a cell dies from pyroptosis?

Background

Pyroptosis is a crucial, inflammasome-mediated form of programmed cell death, distinct from apoptosis and necroptosis, characterized by proinflammatory cytokine release. Its precise identification is vital for understanding its complex roles in health and disease. In cancer, pyroptosis exhibits a dual nature, either promoting or suppressing tumor growth depending on context. Current challenges lie in accurately distinguishing pyroptosis and leveraging its detection for prognostic and therapeutic insights, which this review aims to address.

Study Design

This comprehensive review systematically compiled and analyzed existing literature on pyroptosis detection methods and its biological significance. The authors focused on identifying pyroptosis-related molecules and cellular characteristics that distinguish it from other forms of programmed cell death. The review synthesized information on various techniques used to decipher pyroptosis occurrence in cells, providing insights into its diverse roles in physiological and pathological processes, particularly in cancer development.

Results

The review highlights that pyroptosis is an inflammasome-mediated process, distinct from apoptosis and necroptosis, characterized by cell swelling, membrane rupture, and the release of proinflammatory cytokines like IL-1β and IL-18. Key indicators for its recognition include activation of caspase-1 (or caspase-4/5/11 in non-canonical pathways), cleavage of GSDMD (Gasdermin D) into its N-terminal pore-forming domain, and subsequent membrane pore formation. The detection of specific pyroptosis-related molecules and morphological changes is crucial for accurate identification, serving as potential prognostic indicators and therapeutic targets in various diseases. In cancer, the review elucidates pyroptosis's dual role: it can promote tumor growth by creating an inflammatory microenvironment or suppress it by inducing tumor cell death and enhancing anti-tumor immunity. The context-dependent nature of this role underscores the importance of precise detection methods to guide therapeutic strategies.

Key Findings

  • Pyroptosis is an inflammasome-mediated cell death distinct from apoptosis and necroptosis.
  • Key markers include caspase-1 activation, GSDMD cleavage, and proinflammatory cytokine release.
  • Pyroptosis plays a dual, context-dependent role in cancer development, either promoting or suppressing tumors.
  • Detection of pyroptosis-related molecules can serve as prognostic indicators and therapeutic targets.
  • Accurate identification methods are crucial for understanding its biological function and clinical applications.

Why It Matters

Accurate identification of pyroptosis is critical for advancing therapeutic strategies, especially in oncology. For researchers and clinicians, this review clarifies the distinct markers and methods needed to differentiate pyroptosis from other cell death pathways, enabling more precise mechanistic studies and drug development. Understanding pyroptosis's dual role in cancer means that modulating this pathway could either enhance tumor suppression or inadvertently promote growth, necessitating careful consideration in treatment design. This work provides a foundational resource for developing targeted interventions that leverage pyroptosis for therapeutic benefit, moving closer to personalized medicine approaches.


pyroptosis cell-death inflammasome cancer apoptosis necroptosis
Source: pubmed:42455402 · Ingested 2026-07-15 · Digest: gemini-2.5-flash